Literature DB >> 6514996

Components of injury (haemorrhage and tissue ischaemia) affecting cardiovascular reflexes in man and rat.

R A Little, P E Randall, W S Redfern, H B Stoner, H W Marshall.   

Abstract

The effects of two components of tissue injury, namely fluid loss from the circulation and tissue ischaemia, on cardiovascular reflex activity have been studied. Moderate blood loss (10-20% blood volume) in the unanaesthetized rat increased the slope of the regression line relating heart period to mean arterial blood pressure and usually displaced it to the left (i.e. towards a relative bradycardia). A blood donation of 500 ml (approximately 10% blood volume) increased the Valsalva ratio in conscious man without a change in resting pulse rate. However, a 15 min period of unilateral limb ischaemia in man reduced the Valsalva ratio. The pattern of change in the pulse rat response to the Valsalva manoeuvre produced by limb ischaemia closely resembles that found previously after limb injury in man. There was no evidence that the endogenous opioids were involved in the interaction between limb ischaemia and cardiovascular reflex activity in man.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6514996     DOI: 10.1113/expphysiol.1984.sp002866

Source DB:  PubMed          Journal:  Q J Exp Physiol        ISSN: 0144-8757


  4 in total

Review 1.  Preventable deaths after injury: why are the traditional 'vital' signs poor indicators of blood loss?

Authors:  R A Little; E Kirkman; P Driscoll; J Hanson; K Mackway-Jones
Journal:  J Accid Emerg Med       Date:  1995-03

2.  Faint heart.

Authors:  I D Anderson
Journal:  BMJ       Date:  1989-05-27

3.  Hemorrhagic shock with paradoxical bradycardia.

Authors:  P Barriot; B Riou
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

4.  Development of a large animal model for investigating resuscitation after blast and hemorrhage.

Authors:  J P Garner; S Watts; C Parry; J Bird; E Kirkman
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.